Research reveals GLP-1 receptor agonists influence gut microbiome, enhancing metabolic health and offering anti-inflammatory benefits for diabetes management.
GLP-1 agonists may reshape the gut microbiome
- Post author:admin
- Post published:April 11, 2025
- Post category:uncategorized
- Post comments:0 Comments